A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
Clinical trial NCT03721744 · UNKNOWN
Trial details
- NCT number
- NCT03721744
- Sponsor
- 1Globe Health Institute LLC
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2025-03-01
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.